NCI interns participate in NIH annual Summer Intern Poster Day

Aug 11, 2017

After a summer of hard work, over 250 NCI summer interns presented their cancer research on August 10, 2017, at the NIH annual Summer Intern Poster Day. Part of the NIH Summer Internship Program in Biomedical Research, students were placed across NCI and other institutes to further their education and develop valuable skills in biomedical technology. NIH offers several summer internship opportunities to students of various educational backgrounds and interests. 

NCI interns participate in NIH annual Summer Intern Poster Day
"First in Human" clinical trials at the NIH Clinical Center

"First in Human" documentary features CCR physician-scientists

Aug 9, 2017

The National Cancer Institute's Center for Cancer Research is proud to be a part of "First in Human", a documentary capturing the real-life experiences of doctors, researchers, staff, patients and their caregivers at the NIH Clinical Center. Our CCR physician-scientists are dedicated to leading cutting-edge clinical trials aimed at discovering new and better treatments for cancer. The CCR’s clinical program is the largest of NIH programs housed at the Clinical Center, and we are proud of our history of success. But none of it would be possible without our patients, like Bo, Anita and Lucy. With deep respect, we salute their courage and thank them. Learn more...

"First in Human" documentary features CCR physician-scientists

Mark Gilbert discusses glioblastoma with Newsweek

Jul 25, 2017

In light of Senator John McCain’s diagnosis with glioblastoma, a type of brain cancer, Mark Gilbert, M.D., Chief of CCR’s Neuro-Oncology Branch, discussed the disease with Newsweek on July 20, 2017. Gilbert discussed what glioblastoma is, how it is usually treated, the prognosis and potential treatments currently being developed. He said, “We always encourage patients to enroll in a trial. There are different types of clinical trials ongoing, but the most promising are the ones that target different pathways in the cancer cell that are thought to be essential to the cancer cell’s growth and survival.” Read more…

Mark Gilbert discusses glioblastoma with Newsweek

Center for Cancer Research hosts 10th Annual GIST Clinic

Jul 14, 2017

Patients and specialists from around the world gathered for the 10th Annual Pediatric and Wildtype GIST Clinic, which took place Wednesday, July 5 through Friday, July 7, 2017 at the NIH Clinical Center in Bethesda, Maryland. Occurring once a year, the clinic convenes clinicians, research scientists and advocates from across the country to consult with patients who have GIST. Christine Gonzales, a GIST clinic patient from New Mexico, says, “It’s been super amazing because I’ve never talked to a specialist about this cancer."

Sarcoma Awareness Month

Jun 30, 2017

To recognize Sarcoma Awareness Month this July, we are highlighting our researchers who are advancing research discovery in this field. Learn more...

Gliomatosis Cerebri International logo

2nd International Gliomatosis Cerebri Working Group Conference

Jun 27, 2017

On June 22-23, the NIH hosted the 2nd Gliomatosis Cerebri International Conference that brought together leading neuro-oncologists, neuroscientists and families who have lost a child to the disease. Learn more...

NCI RNA Biology 2017 symposium recap

May 3, 2017

The recent discovery of new classes of RNAs and the demonstration that alterations in RNA metabolism underlie numerous human cancers have resulted in enormous interest among CCR investigators in RNA biology. In order to share the latest research in this exciting field, the CCR Initiative in RNA Biology held its second international symposium April 23-24, 2017, in Natcher Auditorium. Learn more...

Tom Uldrick discusses Castleman’s disease with The Huffington Post

Apr 10, 2017

Tom Uldrick, M.D., Senior Clinican in the HIV and AIDS Malignancy Branch, studies Castleman’s, a rare and aggressive disease, and discussed some of his work with The Huffington Post. He is on the advisory board of the Castleman Disease Collaborative Network (CDCN), which brings researchers from around the world to advance treatment and research for the disease.  Dr. Uldrick  treats David Fajgenbaum, M.D., who founded CDCN and is fighting the disease. It was Dr. Uldrick who gave Fajgenbaum the idea to try singling out specific drugs to test how they work for Castleman disease patients.  Learn more...

Tom Uldrick discusses Castleman’s disease with The Huffington Post

Foregut cancers get new attention at CCR

Mar 27, 2017

The newly formed NIH Foregut Team will focus on cancers of the esophagus, stomach, pancreas, liver, bile ducts and part of the small intestine. Although these tumors are not the most common types of cancers, they are among the deadliest. Learn more...

New publication highlights 2016-2017 CCR research advances

Mar 17, 2017

Milestones is the Center for Cancer Research’s new annual publication that highlights some of the top cancer-research milestones CCR investigators have reached in the last year. The collection presented here merely scratches the surface of the many advances made by CCR scientists but provides a window into the broad spectrum of our activities and the ingenuity of our scientists. Read more...

New publication highlights 2016-2017 CCR research advances